SLC26A4基因突变在耳聋疾病中的作用
柴永川;杨涛;吴皓;
1:上海交通大学医学院附属新华医院耳鼻咽喉-头颈外科
2:上海交通大学耳科学研究所
1 Everett LA,Glaser B,Beck JC,et al.Pendred syndrome iscaused by mutations in a putative sulphate transporter gene(PDS)[J].Nat Genet,1997,17:411.
2 Abe S,Usami S,Hoover DM,et al.Fluctuating sensorineuralhearing loss associated with enlarged vestibular aqueduct mapsto 7q31,the region containing the Pendred gene[J].Am JMed Genet,1999,82:322.
3 Azaiez H,Yang T,Prasad S,et al.Genotype-phenotype cor-relations for SLC26A4-related deafness[J].Hum Genet,2007,122:451.
4 Scott DA,Wang R,Kreman TM,et al.The Pendred syn-drome gene encodes a chloride-iodide transport protein[J].Nat Genet,1999,21:440.
5 Scott DA,Karniski LP.Human pendrin expressed in Xenopuslaevis oocytes mediates chloride/formate exchange[J].Am JPhysiol Cell Physiol,2000,278:C207.
6 Royaux IE,Suzuki K,Mori A,et al.Pendrin,the protein en-coded by the Pendred syndrome gene(PDS),is an apical por-ter of iodide in the thyroid and is regulated by thyroglobulin inFRTL-5 cells[J].Endocrinology,2000,141:839.
7 Zhai Y,Saier MH Jr.A web-based program(WHAT)forthe simultaneous prediction of hydropathy,amphipathicity,secondary structure and transmembrane topology for a singleprotein sequence[J].J Mol Microbiol Biotechnol,2001,3:501.
8 Yang T,Vidarsson H,Rodrigo-Blomqvist S,et al.Tran-scriptional control of SLC26A4 is involved in Pendred syn-drome and nonsyndromic enlargement of vestibular aqueduct(DFNB4)[J].Am J Hum Genet,2007,80:1 055.
9 Wang QJ,Zhao YL,Rao SQ,et al.A distinct spectrum ofSLC26A4 mutations in patients with enlarged vestibular aque-duct in China[J].Clin Genet,2007,72:245.
10 Dai P,Li Q,Huang D,et al.SLC26A4 c.919-2A>G va-ries among Chinese ethnic groups as a cause of hearing loss[J].Genet Med,2008,10:586.
11 Dai P,Stewart AK,Chebib F,et al.Distinct and novelSLC26A4/Pendrin mutations in Chinese and US patients withnonsyndromic hearing loss[J].Physiol Genomics,2009,38:281.
12 Tsukamoto K,Suzuki H,Harada D,et al.Distribution andfrequencies of PDS(SLC26A4)mutations in Pendred syn-drome and nonsyndromic hearing loss associated with en-larged vestibular aqueduct:A unique spectrum of mutationsin Japanese[J].Eur J Hum Genet,2003,11:916.
13 Park HJ,Lee SJ,Jin HS,et al.Genetic basis of hearing lossassociated with enlarged vestibular aqueducts in Koreans[J].Clin Genet,2005,67:160.
14 Campbell C,Cucci RA,Prasad S,et al.Pendred syndrome,DFNB4,and PDS/SLC26A4 identification of eight novel mu-tations and possible genotype-phenotype correlations[J].Hum Mutat,2001,17:403.
15 Albert S,Blons H,Jonard L,et al.SLC26A4 gene is fre-quently involved in nonsyndromic hearing impairment withenlarged vestibular aqueduct in Caucasian populations[J].Eur J Hum Genet,2006,14:773.
16 Bogazzi F,Russo D,Raggi F,et al.Mutations in the SLC26A4(pendrin)gene in patients with sensorineural deafness and en-larged vestibular aqueduct[J].J Endocrinol Invest,2004,27:430.
17 Pera A,Villamar M,Vinuela A,et al.A mutational analysisof the SLC26A4 gene in Spanish hearing-impaired familiesprovides new insights into the genetic causes of Pendred syn-drome and DFNB4 hearing loss[J].Eur J Hum Genet,2008,16:888.
18 Pryor SP,Madeo AC,Reynolds JC,et al.SLC26A4/PDSgenotype-phenotype correlation in hearing loss with enlarge-ment of the vestibular aqueduct(EVA):Evidence that Pen-dred syndrome and non-syndromic EVA are distinct clinicaland genetic entities[J].J Med Genet,2005,42:159.
19 Wangemann P,Itza EM,Albrecht B,et al.Loss of KCNJ10protein expression abolishes endocochlear potential and causesdeafness in Pendred syndrome mouse model[J].BMC Med,2004,2:30.
20 Everett LA,Morsli H,Wu DK,et al.Expression pattern ofthe mouse ortholog of the Pendred's syndrome gene(Pds)suggests a key role for pendrin in the inner ear[J].Proc NatlAcad Sci USA,1999,96:9 727.
21 Wangemann P,Nakaya K,Wu T,et al.Loss of cochlearHCO3-secretion causes deafness via endolymphatic acidifica-tion and inhibition of Ca2+reabsorption in a Pendred syn-drome mouse model[J].Am J Physiol Renal Physiol,2007,292:F1 345.
22 Taylor JP,Metcalfe RA,Watson PF,et al.Mutations of thePDS gene,encoding pendrin,are associated with protein mis-localization and loss of iodide efflux:Implications for thyroiddysfunction in Pendred syndrome[J].J Clin EndocrinolMetab,2002,87:1 778.
23 Rotman-Pikielny P,Hirschberg K,Maruvada P,et al.Re-tention of pendrin in the endoplasmic reticulum is a majormechanism for Pendred syndrome[J].Hum Mol Genet,2002,11:2 625.
24 Cheng SH,Gregory RJ,Marshall J,et al.Defective intracel-lular transport and processing of CFTR is the molecular basisof most cystic fibrosis[J].Cell,1990,63:827.
25 Pera A,Dossena S,Rodighiero S,et al.Functional assess-ment of allelic variants in the SLC26A4 gene involved in Pen-dred syndrome and nonsyndromic EVA[J].Proc Natl AcadSci USA,2008,105:18 608.
26 Choi BY,Stewart AK,Madeo AC,et al.Hypo-functionalSLC26A4 variants associated with nonsyndromic hearing lossand enlargement of the vestibular aqueduct:Genotype-phe-notype correlation or coincidental polymorphisms[J]?HumMutat,2009,30:599.
27 Yang T,Gurrola JG,Wu H,et al.Mutations of KCNJ10 to-gether with mutations of SLC26A4 cause digenic nonsyn-dromic hearing loss associated with enlarged vestibular aque-duct syndrome[J].Am J Hum Genet,2009,84:651.
28 Marcus DC,Wu T,Wangemann P,et al.KCNJ10(Kir4.1)potassium channel knockout abolishes endocochlear potential[J].Am J Physiol Cell Physiol,2002,282:C403.
29 Takeuchi S,Kakigi A,Takeda T,et al.Intravascularly ap-plied K(+)-channel blockers suppress differently the posi-tive endocochlear potential maintained by vascular perfusion[J].Hear Res,1996,101:181.